How to optimize the treatment of early stage Parkinson’s disease

被引:0
|
作者
Fabrizio Stocchi
Laura Vacca
Fabiana G Radicati
机构
[1] IRCCS San Raffaele,Department of Neurology, Institute for Research and Medical Care
关键词
Dopamine Agonist; Selegiline; Pramipexole; Cabergoline; Ropinirole;
D O I
暂无
中图分类号
学科分类号
摘要
The approach to early Parkinson’s disease denotes the communication of the diagnosis and important decisions, such as when and how to start treatment. Evidence based medicine and guidelines indicate which drugs have robust evidence of efficacy and tolerability in this specific population. However, de-novo patients may show different characteristics and they may be in a different phase of their disease.
引用
收藏
相关论文
共 50 条
  • [31] Treatment of advanced stage patients with Parkinson's disease
    Waters, CH
    PARKINSONISM & RELATED DISORDERS, 2002, 9 (01) : 15 - 21
  • [32] Peculiarities of treatment of late stage Parkinson's disease
    Levin, O. S.
    Shindriaeva, N. N.
    Ivanov, A. K.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (08) : 85 - 90
  • [33] Medical treatment of Parkinson's disease in advanced stage
    Jost, W.
    NERVENHEILKUNDE, 2010, 29 (06) : 351 - +
  • [34] Serum somatostatin in early-stage Parkinson's disease
    Shiraishi, M.
    Kobayashi, T.
    Watanabe, H.
    Kamo, T.
    Hasegawa, Y.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (04): : 225 - 229
  • [35] Therapeutic strategies recommended for early stage Parkinson's disease
    Derkinderen, P
    REVUE NEUROLOGIQUE, 2000, 156 : 82 - 90
  • [36] Oculomotor abnormalities in early stage unilateral Parkinson's disease
    Choi, S. -M.
    Kim, B. C.
    Nam, T. -S.
    Kim, J. -T.
    Park, M. -S.
    Kim, M. -K.
    Cho, K. -H.
    MOVEMENT DISORDERS, 2010, 25 (07) : S338 - S338
  • [37] Trial of Prasinezumab in Early-Stage Parkinson's Disease
    Pagano, G.
    Taylor, K. I.
    Anzures-Cabrera, J.
    Marchesi, M.
    Simuni, T.
    Marek, K.
    Postuma, R. B.
    Pavese, N.
    Stocchi, F.
    Azulay, J. -P.
    Mollenhauer, B.
    Lopez-Manzanares, L.
    Russell, D. S.
    Boyd, J. T.
    Nicholas, A. P.
    Luquin, M. R.
    Hauser, R. A.
    Gasser, T.
    Poewe, W.
    Ricci, B.
    Boulay, A.
    Vogt, A.
    Boess, F. G.
    Dukart, J.
    D'Urso, G.
    Finch, R.
    Zanigni, S.
    Monnet, A.
    Pross, N.
    Hahn, A.
    Svoboda, H.
    Britschgi, M.
    Lipsmeier, F.
    Volkova-Volkmar, E.
    Lindemann, M.
    Dziadek, S.
    Holiga, S.
    Rukina, D.
    Kustermann, T.
    Kerchner, G. A.
    Fontoura, P.
    Umbricht, D.
    Doody, R.
    Nikolcheva, T.
    Bonni, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 421 - 432
  • [38] Alterations in muscle synergies in early stage Parkinson's disease
    Daneault, J. F.
    Vergara-Diaz, G.
    Adans-Dester, C.
    Ferreira-Carvalho, G.
    Cheung, V. C. K.
    Bonato, P.
    MOVEMENT DISORDERS, 2016, 31 : S435 - S435
  • [39] Deep brain stimulation in early stage Parkinson's disease
    Charles, David
    Konrad, Peter E.
    Davis, Thomas L.
    Neimat, Joseph S.
    Hacker, Mallory L.
    Finder, Stuart G.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 347 - 348
  • [40] ACQUISITION AND PROCESSING DATA FOR EARLY STAGE OF PARKINSON'S DISEASE
    Geman, Oana
    Pohoata, Sorin
    Graur, Adrian
    REVUE ROUMAINE DES SCIENCES TECHNIQUES-SERIE ELECTROTECHNIQUE ET ENERGETIQUE, 2013, 58 (03): : 324 - 334